Search Results

Return to List
Results 21–40 of 43
Sort By: Relevance | Date | Title
21.

Marijuana Use During Pregnancy and Lactation

Committee Opinion Number 637, July 2015

ABSTRACT Cannabis sativa marijuana is the illicit drug most commonly used during pregnancy The selfreported prevalence of marijuana use during pregnancy ranges from 2 to 5 in most studies A growing number of states are legalizing marijuana for medicinal or recreational purposes and its use by preg...

July 2015

PDF Format
22.

Methamphetamine Abuse in Women of Reproductive Age

Committee Opinion Number 479, March 2011

(Reaffirmed 2013)

ABSTRACT Methamphetamine abuse has continued to increase in the United States since the late 1980s with its use spreading from the West Coast to areas across the country Methamphetamine use in pregnancy endangers the health of the woman and increases the risk of low birth weight and small for gest...

March 2011

PDF Format
23.

Method for Estimating Due Date

Committee Opinion Number 611, October 2014

(Reaffirmed 2016. See also Committee Opinion No. 579)

ABSTRACT Accurate dating of pregnancy is important to improve outcomes and is a research and public health imperative As soon as data from the last menstrual period the first accurate ultrasound examination or both are obtained the gestational age and the estimated due date should be determined di...

October 2014

PDF Format
24.

Moderate Caffeine Consumption During Pregnancy

Committee Opinion Number 462, August 2010

Reaffirmed 2015

ABSTRACT Moderate caffeine consumption less than 200 mg per day does not appear to be a major contributing factor in miscarriage or preterm birth The relationship of caffeine to growth restriction remains undetermined A final conclusion cannot be made at this time as to whether there is a correlat...

August 2010

PDF Format
25.

Nonmedical use of Obstetric Ultrasonography

Committee Opinion Number 297, August 2004

(Reaffirmed 2015)

ABSTRACT The American College of Obstetricians and Gynecologists ACOG has endorsed the Prudent Use statement from the American Institute of Ultrasound in Medicine AIUM discouraging the use of obstetric ultrasonography for nonmedical purposes eg solely to create keepsake photographs or videos The A...

August 2004

PDF Format
26.

Opioid Abuse, Dependence, and Addiction in Pregnancy

Committee Opinion Number 524, May 2012

(Reaffirmed 2016)

ABSTRACT Opioid use in pregnancy is not uncommon and the use of illicit opioids during pregnancy is associated with an increased risk of adverse outcomes The current standard of care for pregnant women with opioid dependence is referral for opioidassisted therapy with methadone but emerging eviden...

May 2012

PDF Format
27.

Oral Health Care During Pregnancy and Through the Lifespan

Committee Opinion Number 569, August 2013

(Reaffirmed 2015)

ABSTRACT Oral health is an important component of general health and should be maintained during pregnancy and through a womans lifespan Maintaining good oral health may have a positive effect on cardiovascular disease diabetes and other disorders In 20072009 35 of US women reported that they did ...

August 2013

PDF Format
28.

Preconception and Prenatal Carrier Screening for Genetic Diseases in Individuals of Eastern European Jewish Descent

Committee Opinion Number 442, October 2009

(Reaffirmed 2014, Replaces No. 298, August 2004)

ABSTRACT Certain autosomal recessive disease conditions are more prevalent in individuals of Eastern European Jewish Ashkenazi descent Previously the American College of Obstetricians and Gynecologists recommended that individuals of Eastern European Jewish ancestry be offered carrier screening fo...

October 2009

PDF Format
29.

Prenatal and Perinatal Human Immunodeficiency Virus Testing - Expanded Recommendations

Committee Opinion Number 635, June 2015

(Replaces Committee Opinion Number 418, September 2008)

ABSTRACT Given the enormous advances in the prevention of perinatal transmission of human immunodeficiency virus HIV it is clear that early identification and treatment of all pregnant women with HIV is the best way to prevent neonatal infection and also improve womens health Furthermore new evide...

June 2015

PDF Format
30.

Prevention of Early-Onset Group B Streptococcal Disease in Newborns

Committee Opinion Number 485, April 2011

(Replaces No. 279, December 2002, Reaffirmed 2015)

ABSTRACT In 2010 the Centers for Disease Control and Prevention revised its guidelines for the prevention of perinatal group B streptococcal disease Although universal screening at 3537 weeks of gestation and intrapartum antibiotic prophylaxis continue to be the basis of the prevention strategy th...

April 2011

PDF Format
31.

Refusal of Medically Recommended Treatment During Pregnancy

Committee Opinion Number 664, June 2016

(Replaces Committee Opinion Number 321, November 2005)

ABSTRACT One of the most challenging scenarios in obstetric care occurs when a pregnant patient refuses recommended medical treatment that aims to support her wellbeing her fetuss wellbeing or both In such circumstances the obstetriciangynecologists ethical obligation to safeguard the pregnant wom...

June 2016

PDF Format
32.

Reproductive Health Care for Incarcerated Women and Adolescent Females

Committee Opinion Number 535, August 2012

ABSTRACT Increasing numbers of women and adolescent females are incarcerated each year in the United States and they represent an increasing proportion of inmates in the US correctional system Incarcerated women and adolescent females often come from disadvantaged environments and have high rates ...

August 2012

PDF Format
33.

Screening for Perinatal Depression

Committee Opinion Number 630, May 2015

(Replaces Committee Opinion Number 453, February 2010)

ABSTRACT Perinatal depression which includes major and minor depressive episodes that occur during pregnancy or in the first 12 months after delivery is one of the most common medical complications during pregnancy and the postpartum period affecting one in seven women It is important to identify ...

May 2015

PDF Format
34.

Screening for Tay - Sachs Disease

Committee Opinion Number 318, October 2005

(Reaffirmed 2014, Replaces No. 162, November 1995)

ABSTRACT TaySachs disease TSD is a severe progressive neurologic disease that causes death in early childhood Carrier screening should be offered before pregnancy to individuals and couples at high risk including those of Ashkenazi Jewish FrenchCanadian or Cajun descent and those with a family his...

October 2005

PDF Format
35.

Smoking Cessation During Pregnancy

Committee Opinion Number 471, November 2010

(Replaces No. 316, October 2005. Reaffirmed 2015)

ABSTRACT Smoking is the one of the most important modifiable causes of poor pregnancy outcomes in the United States and is associated with maternal fetal and infant morbidity and mortality The physical and psychologic addiction to cigarettes is powerful however the compassionate intervention of th...

November 2010

PDF Format
36.

Spinal Muscular Atrophy

Committee Opinion Number 432, May 2009

Reaffirmed 2014

ABSTRACT Spinal muscular atrophy SMA is an autosomal recessive neurodegenerative disease that results from degeneration of spinal cord motor neurons leading to atrophy of skeletal muscle and overall weakness In current practice patients with a family history of SMA are being offered carrier screen...

May 2009

PDF Format
37.

Substance Abuse Reporting and Pregnancy: The Role of the Obstetrician-Gynecologist

Committee Opinion Number 473, January 2011

(Reaffirmed 2014)

Abstract Drug enforcement policies that deter women from seeking prenatal care are contrary to the welfare of the mother and fetus Incarceration and the threat of incarceration have proved to be ineffective in reducing the incidence of alcohol or drug abuse Obstetriciangynecologists should be awar...

January 2011

PDF Format
38.

The Limits of Conscientious Refusal in Reproductive Medicine

Committee Opinion Number 385, November 2007

Reaffirmed 2016

ABSTRACT Health care providers occasionally may find that providing indicated even standard care would present for them a personal moral problema conflict of conscienceparticularly in the field of reproductive medicine Although respect for conscience is important conscientious refusals should be l...

November 2007

PDF Format
39.

The Use of Chromosomal Microarray Analysis in Prenatal Diagnosis

Committee Opinion Number 581, December 2013

(Replaces No. 446, November 2009. Reaffirmed 2015)
(See also Practice Bulletin No. 88)

ABSTRACT Chromosomal microarray analysis is a technique that identifies chromosomal abnormalities including submicroscopic abnormalities that are too small to be detected by conventional karyotyping Like conventional fetal karyotyping prenatal chromosomal microarray analysis requires direct testin...

December 2013

PDF Format
40.

Update on Carrier Screening for Cystic Fibrosis

Committee Opinion Number 486, April 2011

(Reaffirmed 2014, Replaces No. 325, December 2005)

ABSTRACT In 2001 the American College of Obstetricians and Gynecologists and the American College of Medical Genetics introduced guidelines for prenatal and preconception carrier screening for cystic fibrosis The American College of Obstetricians and Gynecologists Committee on Genetics has updated...

April 2011

PDF Format

American Congress of Obstetricians and Gynecologists
409 12th Street SW, Washington, DC  20024-2188 | Mailing Address: PO Box 70620, Washington, DC 20024-9998